MD, PhD, FRCPC | general internal med PGY5 @DalMedSchool | visiting fellow @NDARCnews | substance use & health, drug policy, social epidemiology | he/him/dad
Inspired by @dr_jdlivingston & @CoreyRanger, here is a thread on the recent Alberta safe consumption sites (SCS) review, from my perspective as a doctor training in addiction medicine and co-organizer of an SCS/OPS. 1/
They ran an illegal site for 18 months, with 100+ volunteers saving hundreds & hundreds of lives
Discussion among the crowd about fenantyl coming into local drug supplies as access to prescription pills decreases
This is what we’re now seeing in Halifax
“Don’t wait until fentanyl comes and is killing everyone; start now so you’re ready”
Apr 29, 2019 • 18 tweets • 10 min read
Our commentary on patient-centred care for opioid agonist therapy is published today in @CMAJ
cmaj.ca/content/191/17…
The evidence is clear that opioid agonist treatment with methadone or buprenorphine reduces the risk of death and infection with HIV and hepatitis C
virus (HCV) among people who inject opioids. In many places, OAT isn't available at all and should be implemented urgently.